Depo-Provera, a widely used hormonal contraceptive, has recently been linked to an increased risk of developing meningioma, a type of brain tumor. Even if not cancerous, meningiomas can pose a danger to your health, especially if they grow to a size that may require surgery which can be risky or invasive. If you have been diagnosed with meningioma after Depo-Provera use, you may be eligible to file a lawsuit. Contact the Depo-Provera attorneys at Collins Law today for a free consultation.
Depo-Provera (also known as DMPA) is a contraceptive injection containing medroxyprogesterone acetate, a synthetic form of the hormone progesterone. The injection is administered every three months to prevent pregnancy by suppressing ovulation and altering the uterine lining. Depo-Provera, which is produced by Pfizer, is the well-known brand, but generic options are also available.
However, recent research has raised serious concerns about the long-term safety of Depo-Provera, particularly regarding its link to brain tumors called meningiomas.
In March 2024, a landmark study published in the British Medical Journal by researcher Noémie Roland, a respected epidemiologist with significant experience in public health, shed light on the potential dangers of the use of Depo-Provera. This study analyzed data from over 108,000 women and found that those who used Depo-Provera for more than one year had a 5.6-fold increased risk of developing meningioma compared to non-users.
Pfizer has acknowledged the results of Noemie Roland’s study and has said it will update its product labels to inform patients. However, as of October 29, 2024, we do not see any updated patient information on meningiomas on Pfizer’s online page. Pfizer is still not doing enough to warn patients of the risks. If you or a loved one had been diagnosed with a brain tumor after prolonged use of Depo-Provera, you may be eligible to file a lawsuit. Call Collins Law at (630) 527-1595 to speak with one our nationally recognized attorneys.
Depo-Provera is an injectable contraceptive that is convenient and highly effective when administered properly. In a 2023 survey conducted by the National Center for Health Statistics, approximately 25% of women said they had used Depo-Provera between 2015-2019. The following points illustrate why so many women have chosen to use Depo-Provera:
Depo-Provera works by releasing DMPA, a synthetic progestin hormone, which prevents ovulation and thickens cervical mucus, making it harder for sperm to fertilize an egg, thinning the lining of the uterus to prevent a fertilized egg from implanting. There are two types of injections:
Marketed primarily to women seeking a reliable and long-lasting form of birth control, Depo-Provera has become a widely used contraceptive due to its convenience. Women who do not wish to take daily birth control pills or use devices such as intrauterine devices (IUDs) often turn to Depo-Provera as an alternative. According to the Kaiser Family Foundation (KFF), from 2017-2019, the shot was most commonly used by:
While Depo-Provera offers benefits such as convenience and effectiveness, it also comes with risks that should not be ignored, particularly regarding its association with the development of meningioma.
A meningioma is a type of brain tumor that develops in the meninges, the protective tissues covering the brain and spinal cord. These tumors, which are usually benign, but can be cancerous, grow at a slow pace, which may allow them to remain unnoticed for a long time. However, as they expand, they can press on the brain or spinal cord, sometimes leading to neurological symptoms, functional impairments, and serious complications, depending on their size and exact location.
The symptoms caused by meningiomas vary depending on their growth and location within the skull. If you’ve been using Depo-Provera and are experiencing any of the following symptoms, it’s important to seek medical attention immediately:
Treatment for meningiomas depends on factors like the tumor’s size, growth rate, and impact on brain function. For small, asymptomatic tumors, a watch-and-wait approach with regular imaging may be recommended. For larger or symptomatic tumors, surgery is often the primary option, aiming to remove as much of the tumor as safely possible. Radiation therapy, including targeted forms like stereotactic radiosurgery, is also commonly used when tumors are difficult to remove fully or when surgery poses high risks. In more aggressive cases, radiation is used alongside other treatments to control growth and improve long-term outcomes
As the link between Depo-Provera and meningiomas becomes more well-known, we anticipate filing more lawsuits against Pfizer for failing to adequately warn women about the potential risks of tumor development. If you or a loved one has been diagnosed with meningioma after using Depo-Provera, you may be eligible to file a lawsuit to demand compensation for the damages you have suffered.
Filing a lawsuit against a major pharmaceutical company can be challenging, but with an experienced team of legal professionals, you can build a strong case, if the facts support it. In a Depo-Provera meningioma lawsuit, your attorney will gather medical evidence, listen to expert testimony, and formulate legal arguments to prove:
Navigating a lawsuit against a major corporation like Pfizer requires highly skilled attorneys experienced in pharmaceutical litigation. The accomplished lawyers at Collins Law can ensure your case is handled professionally, including:
At Collins Law, we have years of experience fighting and winning cases against big corporations. And our legal awards, record-setting verdicts, and significant settlements are proof that we are the right attorneys for your case. Call us at (630) 527-1595 to put our experience to work for you.
Yes. At least two plaintiffs have filed lawsuits against Pfizer and others alleging that they developed a meningioma after long-term Depo-Provera use. We expect more lawsuits to be filed as this information becomes more widely known.
Any woman who has been diagnosed with a meningioma brain tumor by a physician after using Depo-Provera, or a generic version of the contraceptive, for a year or more may be eligible to file a lawsuit.
You may still be eligible. It depends on the laws in your state. Call us for a consultation to determine your eligibility.
Studies have established a clear link between long-term use of progesterone-based therapies like Depo-Provera and an increased risk of meningiomas. Worse still, Pfizer, the manufacturer of Depo-Provera, failed to warn women of these risks, and as a result, may have endangered your health. You are entitled to justice. If you have developed a meningioma after using Depo-Provera, don’t wait to take action. The experienced legal team here at Collins Law is ready to help you navigate the complexities of pharmaceutical litigation and fight to get you the compensation you deserve.
Act Now: There are time limits for filing lawsuits, so don’t delay. Fill out our client contact form for a free consultation. Let us fight for your rights and hold Pfizer accountable for the harm you’ve suffered.
Call Us Today: We offer a free, no-obligation consultation to discuss your legal rights and options. Call us at (630) 527-1595 to get started.
"*" indicates required fields